Author

Diane H. Moon

Observed name: Diane H Moon

Institution: Syros Pharmaceuticals (United States)

Observed institutions: Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Manton Center for Orphan Disease Research, Syros Pharmaceuticals (United States)

OpenAlex ID: A5085447883

Poly(A)-specific ribonuclease (PARN) mediates 3′-end maturation of the telomerase RNA component

2015 · Diane H Moon, Matthew Segal, et al. · Nature Genetics · 193

Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells

2020 · Neha Nagpal, Jianing Wang, et al. · Cell stem cell · 111

Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease

2016 · Baris Boyraz, Diane H. Moon, et al. · Journal of Clinical Investigation · 61

Erythroid lineage chromatin accessibility maps facilitate identification and validation of NFIX as a fetal hemoglobin repressor

2023 · Mudit Chaand, Chris Fiore, et al. · Communications Biology · 10

Chromatin Accessibility Mapping of Primary Erythroid Cell Populations Leads to Identification and Validation of Nuclear Factor I X (NFIX) As a Novel Fetal Hemoglobin (HbF) Repressor

2019 · Mudit Chaand, Chris Fiore, et al. · Blood · 3

Mutations in the Poly(A)-Specific Ribonuclease (PARN) Impair Telomerase RNA 3' End Maturation in Dyskeratosis Congenita Patients

2015 · Diane H. Moon, Matthew Segal, et al. · Blood · 3

Works count: 6

Citation count: 381

H-index: 4

I10-index: 4